Abstract. Metastasis-associated genomic alterations have been recognized to play a critical role in tumor metastasis. Primary and metastatic tumor cells in mice and tumors in a patient were studied by cDNA array analysis. Selected genes were determined by RT-PCR and immunohistochemistry. Pathways on changed genes were statistically analyzed. The function of Grb2 was determined by in vitro wound assay. Nodal metastatic cells had a stronger ability of growth and metastasis than primary tumor cells. A total of 376 genes showed a different expression between primary and metastatic cells. The expression of Grb2 and genes in the Grb2-mediated pathways was significantly elevated in the metastases. Elevated levels of Grb2 expression in metastases were related to the distant metastasis of colorectal carcinoma. Blocking the Grb2-SH2 domain signaling transduction inhibited cell motility. Metastasis-associated genes identified by cDNA and tissue microarrays provide potentially valuable information on the metastasis of colorectal tumors. Overexpression of Grb2 may contribute to tumor growth, invasiveness and metastasis.
Introduction
Colorectal carcinoma is one of the most common cancers in the world. Despite advances in diagnosis and treatment, it remains a severe threat to life due to metastasis and associated complications. Significant improvements have been made on the primary tumor thanks to the ongoing new chemotherapeutic agents and improved drug effectiveness; however, almost all patients suffer from fatal metastasis in the end. Therefore, it is essential to gain a comprehensive understanding of the mechanisms of colorectal cancer progression towards metastasis.
At the molecular level, the activation of oncogenes and the inactivation of tumor suppressor genes contribute to the development of colorectal carcinoma. However, in the progression towards metastasis, two distinct classes of genes, metastasis activator (or metastasis promoting) genes and metastasis suppressor genes, may be much more important (1) . Nevertheless, how these genetic alterations result in the metastasis of colorectal carcinomas remains unclear. It is well established that the accumulation of mutant genes during the development of metastatic cells tends to be accompanied by other genetic and epigenetic changes including the loss of heterozygosity (2) , aberrant promoter methylation and/or gene amplifications, all of which can alter gene expression profiles. Therefore, genome-wide monitoring of gene expression is of great importance in order to disclose the numerous diverse events associated with metastasis.
Previous studies were usually based on the comparison of two kinds of cells of different metastatic potentials and/or between the primary tumor cells and the secondary metastatic cells from the same/different patients. However, cells from primary tumor cells may show a different gene expression profile after long-term passages (3) . Thus, cell lines cannot represent the original cancer cells in the patients. Tumor tissues include too many non-malignant cells, such as normal epithelial cells and stroma cells, which affect tumor cell growth and migration (4) . To detect exact differences between primary tumor cells and metastatic cells, we implanted primary tumor cells and metastatic tumor cells into the subcutis of nude mice, where tumor cells grow faster than in other sites and pure tumor cells can be obtained. We performed laser microdissection (LMD) to collect malignant cells. Then, we compared gene profiles between primary tumor cells and metastatic tumor cells by cDNA microarray and screened gene products by immunohistochemistry (IHC) and tissue microarray (TMA). The Pvalue of the two-side Fisher's exact test for the Gene Ontology (GO) category was used to identify significant GO categories and genes and finally possible pathways related to metastasis were explored by using oncogene pathway-analysis. ONCOLOGY REPORTS 19: 1191 -1204 , 2008 New insight into the key proteins and pathways involved in the metastasis of colorectal carcinoma
Materials and methods
Tissue samples and cell line. One patient with advanced gastric carcinoma was taken into account. Fresh tissues at 5 points of the primary tumor (one at the center, four surrounding the tumor) and 5 metastatic lymph nodes were separately digested into single cells and then individually implanted into the subcutis of 10 BALB/c nude mice (Chinese Academy of Science) within 30 min after those tissues were excised from this patient. Two weeks later, tumor tissues were enucleated from the mice. For the LMD, frozen section slides from the same patient were fixed in 70% ethanol for 30 sec, stained with H&E and after dehydration, the sections were dissected with the LMD system (Source of the system). Cells (10,000-20,000) were collected for the total RNA extraction. Then, the above two cell types were analyzed by cDNA array. Another 34 gastric tumors and corresponding tissues (normal mucosa and nodal metastases) were formalin-fixed and paraffin-embedded (from Shanghai Hospital) and used to construct tissue microarray. Tumors were characterized according to the TNM system, differentiation, types, and histopathological gradation according to the WHO standards. A human colorectal cancer cell line SW620 (ATCC CCL-227, USA) was used for a subsequent study, such as investigating the function of genes from cDNA array.
cDNA expression array. Commercially available cDNA expression arrays (Human 14K cDNA Chip V2.0, Shanghai Biochip Co., Ltd. China) were used to compare the gene expression levels between the two types of cancer tissue cells (primary and metastatic cancer cells). This cDNA microarray contains 13824 genes, 10 positive controls and six negative controls.
RNA extraction, cDNA synthesis and hybridization. Total RNAs were extracted from each sample of primary tumor and metastatic tumor tissues collected from the implanted nude mice into 350 μl of RLT lysis buffer (Qiagen, Hilden, Germany). The RNAs were purified with an RNeasy ® mini kit (Qiagen). A 50 μg aliquot of RNA was reversed into cDNA and labeled with Cy3-dCTP or Cy5-dCTP. The hybridization was performed as described previously (7, 8) . Signal intensities of Cy3 and Cy5 from the 13824 spots were qualified and analyzed by substituting backgrounds, using Array Vision software (Imaging Research, Inc, St. Catharines, Ontario, Canada). Subsequently, each signal was normalized so that the average ratio (Cy3:Cy5) of the 10 housekeeping gene signals would be 1.0 and the value of the root (Cy3  2 +Cy5 2 ) of each signal would be kept through the normalization. Each spot was individually visualized and those false-positive results due to the excessive background or other hybridization artifacts were eliminated from the analysis. For ratio calculation, we obtained the average of signal intensities of Cy3:Cy5 of each spot and the ratio >2 or <0.5 was defined as the cut-off benchmark to determine the up-regulated or down-regulated genes. Only genes that were shown in both animal models and LMD were selected for further study.
Gene ontology analysis.
GoMiner arithmetic was applied to GO analysis. Two-side Fisher's exact test was used for the analysis of the GO category and the false discovery rate (FDR) was used to correct the P-value. We chose only GO categories that had a P-value of <0.05 (Log 10 (p)<-1.3) and an FDR of <0.05. Within the significant category, the enrichment Re was given by Re = (n f /n)/(N f /N), where n f was the number of flagged genes within the particular category (i.e. genes whose expression levels are considered to be changed beyond a given threshold), n was the total number of genes within that same category, N f was the number of flagged genes in the entire microarray and N was the total number of genes in the microarray.
Real-time RT-PCR. cDNA from 5 μg of total RNA was synthesized using AMV (Avian myeloblastosis virus) reverse transcriptase (Takara, Japan). Each single-stranded cDNA was diluted for subsequent PCR amplification by monitoring GAPDH as a quantitative control. Real-time RT-PCR was carried out using by SYBR Premix Ex Taq (Perfect real-time) kit (Takara) in the Rotor Gene 3000 system (Corbet Research, Sydney, Australia). Results were analyzed by Rotor Gene 5.0 software.
Tissue microarray. The metastasis-related TMA was constructed as described previously (5) . The TMAs consisted of 1 normal mucosa, 2 primary tumors and 2 or 3 nodal metastatic tumors from each invasive gastrointestinal cancer case. All the cores from one patient were placed in a line.
Immunohistochemistry. The expression of S100A4, Grb2, EPHB2, KRT20 and KISS1 (according to the higher ratio and enrichment of S100A4 and Grb2, the lower ratio and enrichment of EPHB2, KRT20 and KISS1) in normal adjacent-cancer tissues, primary tumors and metastases was analyzed by using TMA and IHC. Preparations were examined with an En Vision kit (Dako, Denmark) according to a standard protocol. The products of the above genes were detected using commercial antibodies against S100A4 (Dako, Lot118, Denmark), Grb2 (Genex Bioscience, GEA7033-1, USA), EPHB2 (Genex Bioscience, GEA8007, USA), KRT20 (Antibody Diagnostica Inc, K-0343, USA), and KISS1 (Santa Cruz, sc-15400, USA). Two observers (Y.G.Z. and C.Y.) evaluated the staining results. A mean percentage of positive tumor cells was determined in at least five areas at x400 magnification and assigned a grade from 0 to 100. The intensity of the immunostaining was scored as follows: weak, 1 + ; moderate, 2 + ; and intense, 3 + . The percentage of positive tumor cells and the staining intensity were multiplied to produce a weighted score for each case. The theoretical limits of the scores ranged from 0 (0% of cells staining) to 300 (100% of the cells staining at 3 + intensity). For the convenience of comparing the differences in the expression levels between tissues and statistical analysis, a dichotomy (negative and positive) was made for each antibody. The cut-off points were raised on the scores, i.e. negative, ≤75% and positive, >75%.
Grb2-SH2 domain-binding antagonists and in vitro wound
assay. The synthesis of a Grb2-SH2 domain-binding antagonist (not commercially) was performed as reported previously (6) . Sulfoxide-cyclized peptidomimetic displays potent binding with the Grb2-SH2 domain with an IC 50 value of 58 nM (Fig. 1) .
The SW620 cells at the center of the plate were scratched away, washed and incubated in a serum-free culture medium for 12 h. The cells were then treated with the Grb2-SH2 domain-binding antagonist in the cell motility assay. The Grb2-SH2 antagonist was added to the cells at the final concentrations of 0, 10, 30, 50 and 100 mM, respectively.
Statistical analysis. The SPSS 11.0 software package for Windows (SPSS Inc., Chicago, IL) was used for all statistical analysis. IHC data were analyzed by the χ 2 test. A P-value of <0.05 was considered statistically significant.
Results
Macroscopic and histopathological findings. Tumors in nude mice implanted with metastatic cells grew more rapidly than those implanted with primary tumor cells (Fig. 2) . The whole tumor tissues were enriched with cancer cells and some inflammatory cells, without obvious stroma cells and epithelial cells of blood/lymph vessels in the primary tumor or in the center of the metastatic tumor. Furthermore, cancer cells in the implanted metastatic tumor penetrated through the basement membrane into the surrounding areas (such as muscles) and vessels ( Fig. 3 ) and formed distant tumor nodules. However, tumors in nude mice implanted primary tumor grew locally and had a complete basement membrane.
cDNA microarray and gene ontology analysis findings. Genes with changed expression in every spot were defined as the commonly up-regulated or down-regulated genes. According to the ratio value, 540 genes were up-regulated and 787 genes were down-regulated. We then examined the significant GO categories and genes by GO analysis. A P-value of <0.05 (log 10 (p) <-1.3) and an FDR of <0.05 in the two-side Fisher's exact test were selected as the significant criteria. Finally, 190 genes fell into the group of the up-regulated genes, while 186 genes fell into the group of the down-regulated genes. These genes were sorted by the enrichment of GO categories (Fig. 4 , Table I ).
Concordance of cDNA microarray with real-time RT-PCR and TMA.
To examine the reliability of our microarray data, we selected six up-regulated genes (GrB2, S100A4, LCK, BMP7, ITPR2 and MFNG) and four down-regulated genes (KRT20, MUCIN3B, KISS1 and EPHB2) and investigated their expression levels by real-time RT-PCR using the same RNA samples that had been used for microarray analysis. The results of real-time RT-PCR were consistent with those from the cDNA microarray data in 8 of the 10 genes (Fig. 5) . Another two had a coincident tendency with the microarray data. Furthermore, to investigate the concordance between the protein levels and results obtained by cDNA microarray as well as RT-PCR, TMA was constructed, which contained 35 tumors and corresponding normal and metastatic tissues ( Fig. 6A and B) . Subsequently, we selected five proteins (GrB2, S100A4, KRT20, KISS1 and EPHB2) to detect their expression levels using TMA and IHC. It was revealed that the levels of GrB2 and S100A4 were higher in metastases than in primary tumors (22/35, 62.9% and 14/35, 40%, respectively), while the levels of KRT20, KISS1 and EPHB2 were significantly lower, or even undetectable, in metastases than in primary tumors (19/35, 54.3%, 24/35, 68.6% and 17/35, 48.6%, respectively) (Table II, Fig. 7 ).
Grb2-mediated pathways are related to metastasis. In our experiment, we found that the ratio of Grb2 in the metastatic cells was 70 times higher than that in the primary tumor cells and its enrichment was also higher in all the data. The elevated levels of Grb2 were seen in the metastases and were related to liver metastases (P<0.05) (Table III) . Thus, we used Grb2 as a target to study possible pathways that contribute to metastasis. Proteins in the Grb2-mediated Ras, Akt and RHo pathways changed more markedly and frequently between the metastasis group and the primary tumor group. Most of the genes involved in these pathways were evaluated or declined (Fig. 8 ). Since the data obtained from cDNA microarray, RT-PCR and TMA all revealed a higher expression of Grb2 in metastatic cells than in primary tumor cells, Grb2 must have a metastatic potential in the progress towards the metastasis of colorectal carcinoma. After using a Grb2-SH2 domain-binding antagonist on tumor cells, the motility of SW620 cells decreased (Fig. 9 ). This result confirmed the role of Grb2 in the pathway of metastasis and the importance of cDNA microarray and TMA. 
Discussion
To obtain precise information on the differences in gene expression profiles between cells of primary colorectal cancer and lymph node metastases, pure and sufficient populations of each type of cells is necessary because stroma cells play a certain role in carcinogenesis. Laser-capture microdissection is a good method to extract the desired cells from tissue specimens, although some non-malignant cells will be left. Implanting fresh tumor cells in nude mice is an effective way to get sufficient pure cells because cancer cells usually grow faster than non-malignant cells. By combining these two Figure 7 . Representative examples of immunohistochemical staining for Grb2, S100A4, KISS1, EPHB2 and KRT20 (x20/200). N, normal tissue; P, primary tumor; M, nodal metastases. The percentage and intensity of the positive cells of KISS1, EPHB2 and KRT20 were lower while the percentage and intensity of the positive cells of Grb2 and S100A4 were higher in metastases than in primary tumor and normal tissues. methods, microarray analysis can effectively identify metastasis-related genes since the interference of host cells is minimized. Furthermore, in order to investigate the levels of their proteins and to confirm its universality, large numbers of specimens are required. TMA is a powerful method which enables hundreds of cases to be detected at one time with the same standard. Thus, combining with TMA and sample preparation, microarray data become reliable and valuable.
Since metastasis arises from rare cells within the primary tumor and a cancer cell must complete at least 10 steps before a secondary tumor is colonized, metastatic cells must have a set of characteristics different from those of primary tumor cells. Studies have shown that metastatic cells have a higher capacity of proliferation, metastasis and invasion than primary tumor cells, which suggests that it is important to understand the underlying mechanism.
Using GO analysis and pathway-analysis, 376 genes were obtained from the 1327 genes. Among these genes, metastasisassociated gene (MTA; NM004689), metastasis suppressor 1 (MTSS1; NM014751) and KISS1 metastasis-suppressor Table 1A . Continued. Table 1A . Continued. (KISS1; NM002256) were first discovered as metastasisrelated genes. The overexpression of MTA1 mRNA is directly correlated with metastatic potential in gastrointestinal carcinoma (7) . KISS1 is expressed in normal colonic mucosa, though its reduced expression is responsible for tumor invasion, distant metastasis and a worse prognosis in gastric carcinoma (8) . MTSS1 is located in a genomic region with a frequent loss of heterozygosity (8q22) and is expressed abundantly in the normal gastric mucosa, suggesting its role in gastric carcinogenesis (9) . In addition, S100A4 Table 1B . Continued. - Table II . Protein levels in metastases and primary tumors.
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Staining results of metastases compared with the primary tumors after dichotomizing the results for the 35 patients of the study population with nodal metastases. S100A4  35  6  20  9  0  GrB2  35  3  22  7  3  KISS1  35  3  20  0  12  CK20  35  5  17  1  12  EphB2  35  10  12  3 
B, Different levels of positive staining of the five proteins in the concordant patients. S100A4  20  14  1  5  GrB2  22  7  0  15  KISS1  20  8  12  0  CK20  17  10  7  0  EphB2  12  4  7  1 - Table III . Relationship between positive staining of Grb2 in the primary tumor and the metastases and pathological characteristics. -
+, Positive staining of Grb2 in the primary tumor; >, elevated levels of Grb2 staining in the metastasis site compared with in the primary site. a P<0.05.
-
, which was up-regulated in the present study, is known to modify the cytoskeleton and focal adhesion and to trigger several other events in tumor cells (10) . A higher expression of the S100A4 protein is closely associated with tumor progress and distant metastasis in many types of cancers (11) . A number of genes showing a down-regulated expression in colorectal metastatic cells have been associated with metastasis directly or indirectly, which include a decay accelerating factor for complement (DAF; NM000574), a cell-membrane-complement regulator and two adhesion molecules, i.e. claudin2 (CLDN2; NM020384) and several metabolism-related genes including carbonic anhydrase XII (CA12; NM00128), UDP-N-acetyl-α-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3; NM004482), catechol-O-methyltransferase (COMT; NM000754) and signal transduction genes: annexin A10 (ANXA10; NM007193), annexin A1 (ANXA1; 000700) and Keratin 20 (KRT20; NM019010). DAF is significantly elevated in patients with colorectal cancer and can be excreted into the stool and thus can be detected by ELISA (12) . Our present study showed that adenocarcinoma exposed to complementary attack in the early stages may up-regulate DAF in order to protect malignant cells from complementary lysis. This is similar to the results obtained by Nowicki et al (13) . CLDN2 is critical for maintaining cell-cell adhesions in epithelial cell sheets and acts as selective barriers, because it is down-regulated markedly by Raf-1, which activates signal transduction and stimulates cell proliferation. CLDN2 is increased in the early phase of carcinogenesis, though is reduced during progression to invasive diseases (14) . Most of the gene encoded enzymes necessary for cell growth and metabolism are involved in metastasis, which is consistent with the observation that CA12, a hypoxia-inducible gene, is a marker of good prognosis in invasive breast carcinoma, which has an inverse relationship with VEGF (vascular endothelial growth factor) (15) . A low expression of GALNT3 is associated with a poorly differentiated tumor, poor pathological stage and nodal metastases in lung carcinoma patients (16) . A low activity of COMT may contribute to the progression of breast cancer because it is responsible for detoxification of catecholestrogens which may prevent the genesis and arrest the progress of the disease (17) . Therefore, the abnormity of enzyme metabolism may be a crucial step for metastasis in various cancers. Signal molecules: ANXA10, a calcium-binding protein participating in diverse biological processes, is a marker of cell differentiation and growth arrest since the down-regulation of ANXA10 is related to vascular invasion and progression of hepatic carcinoma and poor prognosis and perhaps repressed by S100A4 and mtp53 (18) . The down-regulation of ANXA1 is significantly associated with advanced T stage, lymph node metastases, advanced disease stage and poor differentiation in HNSCC, which identifies ANXA1 as an effective differentiation marker (19) . EPHB2, a receptor tyrosine kinase, may achieve its tumor-suppressing function through the regulation of cell survival, adhesion and migration since a progressive loss of EPHB2 is accompanied by the progress towards the metastases of colorectal carcinoma (20) . Notably, the KRT20 gene was down-regulated in metastatic cells rather than in primary cancer cells in microarray, RT-PCR and IHC data. IHC also showed that KRT20 was reduced in cancer tissues, which was consistent with the results from previous publications (21) . Hence KRT20 may be a useful prognostic marker, which gradually decreases with the progress to metastasis of colorectal carcinoma.
Among other genes showing up-regulated expression in metastatic cells, we noted the presence of the growth factor receptor-bound protein gene (Grb2; NM002086), lymphocytespecific protein tyrosine kinase gene (LCK; NM005356), EPHB4 gene (EPHB4; NM004444), LAT1-3TM gene (LAT1-3TM; NM031211), cyclin L1 gene (CCNL1; BX538238), cathepsin D (CTSD; NM001909), bone morphogenetic protein 7 (BMP7; NM001719) and cyclindependent kinase 6 gene (CDK6; NM001259). Grb2 is an SH2 domain-containing docking module that participates in the signaling of numerous oncogenic growth factor receptor protein-tyrosine kinases (PTKs), the de-regulation of which contributes to cellular transformation and metastasis (22) . LCK sequence appears highly homologous to oncogene p60-src which is often implicated in human cancers and could favor metastases by facilitating the loss of adhesion (23) . EPHB4 is a candidate gene of metastatic potential because in EPHB4 knockout mice it leads to nearly 80% reduction in tumor and reduced tumor microvasculature (24) . LAT1-3TM has a similar sequence to the amino acid transporter LAT1, the high expression of which is related to invasion and liver metastasis tumors (25) . The amplification of cyclin L1, a candidate oncogene, is associated with lymph node metastases in head and neck squamous cell carcinoma according to FISH (fluorescence in situ hybridization) and TMA (26) . CDK6 is required for cell cycle progression (G1-S phase transition) by binding D cyclin and forming D cyclin/CDK6 complex. CTSD expression is a possible predictor of lymph node metastases in submucosal colorectal cancer (27) . Since BMP7 was able to inhibit serum starvationinduced apoptosis and induce motility and invasiveness of PC3 prostate cells, BMP7 could contribute to cancer cell growth and metastasis in the case of prostate cancer (28) . The enhanced expression of these genes may play a direct or indirect role in the mechanisms of colorectal cancer metastasis including accelerated metabolism, impaired regulation of cell cycle, imbalance of adhesion and disadhesion and the deregulation of phosphorylation and transporters.
In this study, we selected five proteins (GrB2, S100A4, KRT20, KISS1 and EPHB2), as discussed above, to detect their expression levels using TMA and IHC. The levels of GrB2 and S100A4 were higher in metastases than in primary tumors and the levels of KRT20, KISS1 and EPHB2 were apparently decreased, or even undetectable, in metastases compared with primary tumors in most of the cases, in agreement with the results from previous reports (15, (34) (35) (36) .
In our experiment, we noted that Grb2 had the highest ratio and enrichment. The IHC results also confirmed the reliability in a large number of tumor tissues and revealed that a tumor in patients with a higher expression in nodal metastases than in the primary tumor easily metastasizes to the liver. Thus, we used Grb2 as the target to investigate pathways based on the original data. Grb2 especially mediates the MAPKK, Akt and RHo pathways. Most of the genes involved in these pathways were elevated in metastatic cells compared with primary tumor cells, which suggests a critical role of Grb2-mediated pathways in the process of metastasis.
Therapeutic intervention has been approached through the down-regulation of the affected pathways including the Grb-SH2 signal pathway (29) . After using a Grb2-SH2 domain-binding antagonist, SW620 cells with a high metastatic potential showed a slower motility at the concentration of 30 mM. Thus, it is possible that Grb2 contributes to high-grade metastasis.
In conclusion, our results reveal not only new information about metastasis-related genes but also a novel association between known genes and metastasis. The identified relationship between cancer characteristics and genes will help to further investigate the function of the genes. In addition, our observations that the Grb2-mediated MAPK pathway plays a key role in the progress and function of metastasis of colorectal carcinoma may prove useful for identifying novel therapeutic targets.
